PR93495

TEL AVIV, Israel, December 6, 2021 /PRNewswire=KYODO JBN/--

MedTech Startup Focused on Home Monitoring for Patients with Congestive Heart

Failure and Other Chronic Diseases Receives the "Future Unicorn" Innovation

Award from E&T

E&T Magazine, the official publication of the Institution of Engineering and

Technology (IET), presented its "Future Unicorn" award to Donisi Health

[https://donisihealth.com/](Donisi), a MedTech company enabling patients with

Congestive Heart Failure (CHF) and other chronic diseases monitor their health

status. Donisi has the only clinically validated, contact-free technology that

can detect signs of pulmonary congestion remotely, supporting the continuum of

care for remote patient monitoring and hospital-at-home services.

Based upon FDA-cleared technology [

https://www.prnewswire.com/il/news-releases/fda-grants-donisi-de-novo-clearance-for-innovative-contact-free-multiparameter-health-sensing-solution-301264839.html]

and backed by 11 granted patents, Donisi's AI-based system detects and analyzes

multiple health bio-indicators simultaneously, delivering clinically meaningful

insights and notifications of changes in key health indicators.

"We are honored to receive this prestigious award from E&T Magazine confirming

Donisi is on the right path to bringing a disruptive solution to meaningfully

impact patient health," said Donisi's CEO, Yair Brosh. "We are focused on

applying our breakthrough technology to address real unmet needs, starting with

the high readmission rate for CHF patients leaving the hospital who need to

monitor pulmonary congestion at home. We greatly appreciate this recognition of

our team's efforts."

IET President Sir Julian Young said: "These annual awards celebrate the

achievements of the most outstanding innovators across engineering and

technology. Our finalists come from a diverse range of companies and academic

institutions from across the world, with their innovations tackling major

economic and societal challenges. With the IET's mission to inspire excellence

in engineering and technology, we are so proud to demonstrate our support,

putting ground-breaking innovations in the spotlight and helping to advance

this essential and fundamental work."

The first, and only, medical device to receive FDA clearance for detection of

multiple cardiopulmonary health indicators without physical contact with the

patient, Donisi's system applies proprietary optics, algorithms, and artificial

intelligence to remotely detect and analyze surface-level nano-vibrations

caused by the function of internal organs such as the heart and lungs. Clinical

results demonstrate that Donisi's technology maintains medical grade accuracy

for people with different medical and physical conditions (physique, skin tone,

etc.), without needing to remove clothing or connect the patient to wires or

patches.

For more information please contact:

Hannah Carimi

Donisi Health, Israel

hannah.carimi@donisihealth.com

Michael Seggev

Donisi Health, US

michael.seggev@donisihealth.com

SOURCE: ContinUse Biometrics, dba Donisi Health, Donis